Showing results (121-130 of 193) with videos related to
Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2015
A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate CancerKristell L S Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapyMarleen Melis, Jan de Swart, Monique de Visser, et al.Arthritis and Rheumatism|May 14, 2013
Hsp90 inhibition protects against biomechanically induced osteoarthritis in ratsMichiel Siebelt, Holger Jahr, Harald C Groen, et al.EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Generation of fluorescently labeled tracers - which features influence the translational potential?Fijs W B van Leeuwen, Bart Cornelissen, Federico Caobelli, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Indication for different mechanisms of kidney uptake of radiolabeled peptidesMartin Gotthardt, Julliëtte van Eerd-Vismale, Wim J G Oyen, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 7, 2020
Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11Eric J Meester, Boudewijn J Krenning, Erik de Blois, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2009
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumoursMarleen Melis, Magda Bijster, Monique de Visser, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapyEric P Krenning, Roelf Valkema, Dik J Kwekkeboom, et al.EJNMMI Research|June 28, 2015
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountMark W Konijnenberg, Wout A P Breeman, Erik de Blois, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 8, 2015
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and TherapySimone U Dalm, Anieta M Sieuwerts, Maxime P Look, et al.Pageof 20